Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects

Zhengming Tian1, Xunming Ji1,2, Jia Liu1

  • 1Laboratory of Brain Disorders, Beijing Institute of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Capital Medical University, Beijing 100069, China.

Insights

Vascular cognitive impairment and dementia (VCID) is linked to chronic brain hypoperfusion. Neuroinflammation triggered by this condition plays a key role in VCID development, offering new treatment targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Cerebrovascular Medicine

Background:

  • Vascular cognitive impairment and dementia (VCID) is the second leading cause of dementia globally.
  • VCID results from chronic low brain perfusion, leading to cognitive dysfunction.
  • Current VCID treatment strategies are limited due to ambiguous classification and diagnostic criteria.

Purpose of the Study:

  • To explore neuroinflammation mechanisms in VCID induced by ischemia and hypoxia.
  • To emphasize the role of neuroinflammation in VCID development.
  • To provide insights for VCID prevention and treatment.

Main Methods:

  • Review of existing literature on neuroinflammation in VCID.
  • Analysis of immune cells, mediators, and signaling pathways involved.
  • Focus on ischemia and hypoxia induced by chronic hypoperfusion.

Main Results:

  • Chronic hypoperfusion induces ischemia and hypoxia, overactivating neuroinflammation.
  • Neuroinflammation contributes to apoptosis and blood-brain barrier damage in VCID.
  • Immune responses are critical in the pathogenesis of VCID.

Conclusions:

  • Neuroinflammation is a significant factor in the development and progression of VCID.
  • Understanding neuroinflammatory pathways offers potential therapeutic targets for VCID.
  • Further research into immune mechanisms can guide novel treatment strategies for VCID.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
689
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
266
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
83
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
182
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
214
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
12.6K